Immunize Against Shingles With the New Vaccine, Shingrix

December 2017

Please see the January 2018 CDC recommendations for the use of herpes zoster vaccines.

The new zoster vaccine, Shingrix (SHING-riks), will be preferred over Zostavax...because Shingrix seems more effective.

Patients will hear that Shingrix is about 97% effective for preventing shingles...compared to about 51% with Zostavax.

This works out to preventing one case of shingles over 3 years for every 37 patients getting Shingrix...versus 59 patients with Zostavax.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote